Lisa M Sodeika
First SEC filing: May 14, 2015 · Latest: May 14, 2015
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 28, 2019 | CVSA | A | 6,900 | · | · | 6,900 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 28, 2019 | CVSA | A | 2,210 | · | · | 24,151 Direct | +10.07% | Acquired | (price as of 2026-10-05) |
| Aug. 27, 2019 | CVSA | F | 1,524 | $43.86 | $66,843 | 21,941 Direct | -6.49% | Disposed | 185.9% (price as of 2026-10-05) |
| Aug. 27, 2019 | CVSA | A | 5,201 | $43.86 | $228,116 | 23,465 Direct | +28.48% | Acquired | 185.9% (price as of 2026-10-05) |
| Aug. 26, 2019 | CVSA | F | 245 | $45.55 | $11,160 | 18,264 Direct | -1.32% | Disposed | 175.3% (price as of 2026-10-05) |
| Aug. 25, 2019 | CVSA | F | 324 | $44.94 | $14,561 | 18,509 Direct | -1.72% | Disposed | 179.0% (price as of 2026-10-05) |
| Aug. 23, 2019 | CVSA | F | 244 | $44.94 | $10,965 | 18,833 Direct | -1.28% | Disposed | 179.0% (price as of 2026-10-05) |
| Aug. 22, 2019 | CVSA | F | 144 | $50.96 | $7,338 | 19,077 Direct | -0.75% | Disposed | 146.1% (price as of 2026-10-05) |
| May 13, 2019 | CVSA | F | 458 | $45.46 | $20,821 | 17,471 Direct | -2.55% | Disposed | 175.8% (price as of 2026-10-05) |
| Aug. 27, 2018 | CVSA | F | 324 | $48.70 | $15,779 | 17,929 Direct | -1.78% | Disposed | 157.5% (price as of 2026-10-05) |
| Aug. 27, 2018 | CVSA | F | 245 | $48.70 | $11,932 | 18,253 Direct | -1.32% | Disposed | 157.5% (price as of 2026-10-05) |
| Aug. 24, 2018 | CVSA | F | 244 | $48.75 | $11,895 | 18,498 Direct | -1.30% | Disposed | 157.2% (price as of 2026-10-05) |
| Aug. 23, 2018 | CVSA | F | 693 | $49.05 | $33,992 | 17,174 Direct | -3.88% | Disposed | 155.6% (price as of 2026-10-05) |
| Aug. 23, 2018 | CVSA | A | 2,359 | $49.05 | $115,709 | 17,867 Direct | +15.21% | Acquired | 155.6% (price as of 2026-10-05) |
| Aug. 22, 2018 | CVSA | A | 4,847 | $49.05 | $237,745 | 4,847 Direct | · | Acquired | 155.6% (price as of 2026-10-05) |
| Aug. 22, 2018 | CVSA | A | 1,753 | $49.05 | $85,985 | 1,753 Direct | · | Acquired | 155.6% (price as of 2026-10-05) |
| Aug. 22, 2018 | CVSA | A | 1,960 | · | · | 17,076 Direct | +12.97% | Acquired | (price as of 2026-10-05) |
| May 12, 2018 | CVSA | F | 456 | $46.45 | $21,181 | 15,116 Direct | -2.93% | Disposed | 169.9% (price as of 2026-10-05) |
| Sept. 17, 2017 | CVSA | F | 357 | $34.00 | $12,138 | 15,572 Direct | -2.24% | Disposed | 268.8% (price as of 2026-10-05) |
| Aug. 26, 2017 | CVSA | F | 260 | $34.00 | $8,840 | 15,929 Direct | -1.61% | Disposed | 268.8% (price as of 2026-10-05) |
| Aug. 23, 2017 | CVSA | A | 8,064 | · | · | 8,064 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 23, 2017 | CVSA | A | 3,136 | · | · | 3,136 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 23, 2017 | CVSA | A | 3,320 | · | · | 16,189 Direct | +25.80% | Acquired | (price as of 2026-10-05) |
| May 12, 2017 | CVSA | F | 483 | $39.70 | $19,175 | 12,869 Direct | -3.62% | Disposed | 215.8% (price as of 2026-10-05) |
| Aug. 26, 2016 | CVSA | F | 260 | $23.48 | $6,105 | 13,352 Direct | -1.91% | Disposed | 434.0% (price as of 2026-10-05) |
| Aug. 25, 2016 | CVSA | A | 3,725 | · | · | 3,725 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 25, 2016 | CVSA | A | 11,175 | · | · | 11,175 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 25, 2016 | CVSA | A | 4,420 | · | · | 13,612 Direct | +48.09% | Acquired | (price as of 2026-10-05) |
| May 12, 2016 | CVSA | F | 478 | $19.47 | $9,307 | 9,192 Direct | -4.94% | Disposed | 544.0% (price as of 2026-10-05) |
| Aug. 26, 2015 | CVSA | A | 1,652 | $26.23 | $43,332 | 1,652 Direct | · | Acquired | 378.0% (price as of 2026-10-05) |
| Aug. 26, 2015 | CVSA | A | 15,248 | $26.23 | $399,955 | 15,248 Direct | · | Acquired | 378.0% (price as of 2026-10-05) |
| Aug. 26, 2015 | CVSA | A | 3,340 | · | · | 9,670 Direct | +52.76% | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 28, 2019 | CVSA | Employee Stock Option (Right to Buy) | Common Stock | $43.39 | Aug. 28, 2029 | 6,900 | Acquired |
| Aug. 22, 2018 | CVSA | Non-qualified Stock Option (Right to Buy) [F2] | Common Stock | $49.05 | Aug. 22, 2028 | 4,847 | Acquired |
| Aug. 22, 2018 | CVSA | Incentive Stock Option (Right to Buy) [F2] | Common Stock | $49.05 | Aug. 22, 2028 | 1,753 | Acquired |
| Aug. 23, 2017 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock | $33.90 | Aug. 23, 2027 | 8,064 | Acquired |
| Aug. 23, 2017 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock | $33.90 | Aug. 23, 2027 | 3,136 | Acquired |
| Aug. 25, 2016 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock | $23.78 | Aug. 25, 2026 | 3,725 | Acquired |
| Aug. 25, 2016 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock | $23.78 | Aug. 25, 2026 | 11,175 | Acquired |
| Aug. 26, 2015 | CVSA | Non-qualified Stock Option (Right to Buy) | Common Stock | $26.23 | Aug. 26, 2025 | 1,652 | Acquired |
| Aug. 26, 2015 | CVSA | Incentive Stock Option (Right to Buy) | Common Stock | $26.23 | Aug. 26, 2025 | 15,248 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | $401,148 | · | · | · | $219,317 | · | · | $990,353 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.